Last update Aug. 23, 2021

Tirofiban Hydrochloride

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

It is a non-peptide antagonist of the platelet surface receptor GP IIb/IIIa, preventing its binding with fibrinogen and blocking platelet aggregation.
Indicated in the prevention of myocardial infarction in acute coronary syndromes and in early percutaneous coronary intervention (PCI).
Administration by intravenous infusion for a maximum of 4-5 days.

At the date of the last update, there was no available published data on its excretion in breast milk.

Its pharmacokinetic data (large volume of distribution, moderately high molecular weight and short half-life) make it unlikely that it will pass into breast milk in a clinically significant quantity.

The risk can be minimized by waiting to breastfeed again between 6 and 8 hours after the last administration of the medicine.

The limitation to breastfeed will depend on the clinical situation of the mother.


We do not have alternatives for Tirofiban Hydrochloride.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Tirofiban Hydrochloride in other languages or writings:


Tirofiban Hydrochloride belongs to this group or family:


Main tradenames from several countries containing Tirofiban Hydrochloride in its composition:


Variable Value Unit
Molecular weight 495 daltons
Protein Binding 65 %
VD 0.3 -0.6 l/Kg
pKa 3.17 -
1.4 - 2.2 hours


  1. AEMPS. Tirofiban. Ficha técnica. 2020 Full text (in our servers)
  2. Cipher Pharm. Tirofiban. Drug Summary. 2018 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM